MedTrace Logo

Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen

NCT04805840 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 93

Last updated 2021-11-18

No results posted yet for this study

Summary

This study aims to assess how an at-home COVID-19 frequent testing regimen using the CoV-SCAN test kit and a paired phone application to help interpret the test result compares to once-a-week or three-times-a-week polymerase chain reaction (PCR) (molecular) testing to identify a SARS-CoV-2 infection.

Employees and cast members at Media and Entertainment Company and its affiliates will be recruited to test whether frequent use of CoV-SCAN will perform as well or better than weekly molecular testing and at least as well as three-times-a-week molecular testing.

Conditions

  • Covid19

Interventions

DEVICE

CoV-SCAN rapid COVID-19 antigen test

SARS-CoV-2 rapid antigen screening test

Sponsors & Collaborators

Principal Investigators

  • Kathrine Meyers, DrPH, MS, MPP · Assistant Professor

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-19
Primary Completion
2021-06-02
Completion
2021-07-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04805840 on ClinicalTrials.gov